MedPharm, Ltd Upgrades and Expands Its Formulation Development Labs, Analytical Labs and Clinical Manufacturing Suites in the United Kingdom

May 16, 2021

MedPharm Ltd, the world leader in formulation development and analytical services for topical and transdermal products, has announced a £1.5M refurbishment that will increase laboratory space in the UK by 35%.

The renovations will incorporate increased investment in automated technologies to maintain MedPharm’s  leading and pioneering edge in the pharmaceutical formulation development and testing sectors for topical and transdermal products.

Scheduled to be completed in November 2021, the increased capacity will allow MedPharm to continue meeting the growing demand for its topical and transdermal services.

Expanding and reimagining the laboratory space will enable a streamlined workflow which allows MedPharm scientists to provide optimal service to its clients for years to come according to Dr Rob Turner, General Manager UK, MedPharm.

“We are excited to be renovating our formulation and analytical laboratories, clinical manufacturing suites and personnel workspace to ensure our operations and capabilities remain state of the art. During the renovations, we will take extensive steps to de-risk the process and do not expect any disruption to our existing services, quality of scientific deliverables and client commitments throughout the refurbishment. We have been supporting clients from Guildford for 15 years and this renovation will secure our footprint here in Surrey for years to come.”


About MedPharm
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm is expert at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading 
performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.